Plasmablastic lymphoma

Cancers in People with HIV and AIDS: Progress and Challenges

Volumn , Issue , 2014, Pages 223-234

  Wang, Huan You ^a   Wong Sefidan, Ida ^b   Reid, Erin ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930244952     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-0859-2_16     Document Type: Chapter

References (62)

1. Antinori A, Cingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS. 2001;15:1483-91.
2. Bibas M, Grisetti S, Alba L, Picchi G, Del Nonno F, Antinori A. Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfi lgrastim chemotherapy and lenalidomide alone. J Clin Oncol. 2010;28:e704-8.
3. Bishop JA, Westra WH. Plasmablastic lymphoma involving the parotid gland. Head Neck Pathol. 2010;4:148-51.
4. Bose P, Thompson C, Gandhi D, Ghabach B, Ozer H. AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib. Eur J Haematol. 2009;82:490-2.
5. Boy SC, van Heerden MB, Babb C, van Heerden WF, Willem P. Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas. Oral Oncol. 2011;47:883-7.
6. Brahmania M, Sylwesterowic T, Leitch H. Plasmablastic lymphoma in the ano-rectal junction presenting in an immunocompetent man: A case report. J Med Case Rep. 2011;5:168.
7. Carbone A, Gloghini A. Plasmablastic lymphoma: One or more entities? Am J Hematol. 2008;83:763-4.
8. Carbone A, Gloghini A, Canzonieri V, Tirelli U, Gaidano G. AIDS-related extranodal non-Hodgkin's lymphomas with plasma cell differentiation. Blood. 1997;90:1337-8.
9. Castillo JJ, Reagan JL. Plasmablastic lymphoma: A systematic review. Scientifi cWorldJournal. 2011;11:687-96.
10. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: Lessons learned from 112 published cases. Am J Hematol. 2008;83:804-9.
11. Castillo JJ, Winer ES, Stachurski D, et al. Clinical and pathological differences between human immunoDeficiency virus-positive and human immunoDeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010a;51:2047-53.
12. Castillo JJ, Winer ES, Stachurski D, et al. Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma. Oncologist. 2010b;15:293-9.
13. Castillo JJ, Furman M, Beltran BE, et al. Human immunoDeficiency virus-associated plasmablastic lymphoma: Poor prognosis in the era of highly active antiretroviral therapy. Cancer. 2012;118:5270-7.
14. Cha JM, Lee JI, Joo KR, et al. A case report with plasmablastic lymphoma of the jejunum. J Korean Med Sci. 2010;25:496-500.
15. Chabay P, De Matteo E, Lorenzetti M, et al. Vulvar plasmablastic lymphoma in a HIV-positive child: A novel extraoral localisation. J Clin Pathol. 2009;62:644-6.
16. Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol. 2004;28:1401-16.
17. Chang CC, Zhou X, Taylor JJ, et al. Genomic profi ling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): Revealing signifi cant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol. 2009;2:47.
18. Chuah KL, Ng SB, Poon L, Yap WM. Plasmablastic lymphoma affecting the lung and bone marrow with CD10 expression and t(8;14)(q24;q32) translocation. Int J Surg Pathol. 2009;17:163-6.
19. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28: 736-47.
20. Dawson MA, Schwarer AP, McLean C, et al. AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation-treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. Haematologica. 2007;92:e11-2.
21. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunoDeficiency virus infection. Blood. 1997;89: 1413-20.
22. Dholaria B, Alapat D, Pandey T, Agarwal A. Plasmablastic lymphoma of the retroperitoneum in an HIV-and HCV-positive patient: Hard to diagnose and harder to treat. Med Oncol. 2012;29:3529-34.
23. Dong HY, Scadden DT, de Leval L, Tang Z, Isaacson PG, Harris NL. Plasmablastic lymphoma in HIV-positive patients: An aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29:1633-41.
24. Francischini E, Martins FM, Braz-Silva PH, Magalhaes MH, Ortega KL. HIV-associated oral plasmablastic lymphoma and role of adherence to highly active antiretroviral therapy. Int J STD AIDS. 2010;21:68-70.
25. Gaidano G, Cerri M, Capello D, et al. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol. 2002;119:622-8.
26. Gao J, Kong X, Zhong D, et al. An uncommon case of epidural plasmablastic lymphoma presents as spinal cord compression. Clin Neurol Neurosurg. 2013;115:2301-3.
27. Gloghini A, Dolcetti R, Carbone A. Lymphomas occurring specifi cally in HIV-infected patients: From pathogenesis to pathology. Semin Cancer Biol. 2013;23:457-67.
28. Goedhals J, Beukes CA, Hardie D. HHV8 in plasmablastic lymphoma. Am J Surg Pathol. 2008;32:172. author reply 72-4.
29. Goto H, Hagiwara S, Hirai R, et al. Case of relapsed AIDS-related plasmablastic lymphoma treated with autologous stem cell transplantation and highly active antiretroviral therapy. Rare Tumors. 2011;3:e11.
30. Guan B, Zhang X, Ma H, Zhou H, Zhou X. A meta-analysis of highly active anti-retroviral therapy for treatment of plasmablastic lymphoma. Hematol Oncol Stem Cell Ther. 2010;3:7-12.
31. Hansra D, Montague N, Stefanovic A, et al. Oral and extraoral plasmablastic lymphoma: Similarities and differences in clinicopathologic characteristics. Am J Clin Pathol. 2010;134:710-9.
32. Hausermann P, Khanna N, Buess M, et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: An unrecognized cutaneous manifestation. Dermatology. 2004;208:287-90.
33. Isaacson PG, Campo E, Harris NL. Large B-cell lymphoma arising in HHV-8-associated multicentric Castleman disease. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classifi cation of tumors of haematopoietic and lymphoid tissues. 4th ed. Geneva: WHO Press; 2008. p. 258-9.
34. Lester R, Li C, Phillips P, et al. Improved outcome of human immunoDeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: A report of two cases. Leuk Lymphoma. 2004;45:1881-5.
35. Liu JJ, Zhang L, Ayala E, et al. Human immunoDeficiency virus (HIV)-negative plasmablastic lymphoma: A single institutional experience and literature review. Leuk Res. 2011;35:1571-7.
36. Makis W, Ciarallo A, Lisbona R. Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: Staging with 18 F-FDG PET/CT. Acta Radiol. 2011;52:970-2.
37. Mani D, Guinee Jr DG, Aboulafia DM. AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: A diagnostic dilemma. World J Gastroenterol. 2008;14:4395-9.
38. Martinez D, Valera A, Perez NS, et al. Plasmablastic transformation of low-grade B-cell lymphomas: Report on 6 cases. Am J Surg Pathol. 2013;37:272-81.
39. NCCN Guidelines. 2013. www.nccn.org
40. Noy A, Chadburn A, Lensing S, Moore P. Plasmablastic lymphoma is curable the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium (AMC). In. American society of hematology annual meeting 2013.
41. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002; 99;2331-6.
42. Ouansafi I, He B, Fraser C, et al. Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement. Am J Clin Pathol. 2010;134:972-81.
43. Pan ZG, Zhang QY, Lu ZB, et al. Extracavitary KSHV-associated large B-Cell lymphoma: A distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases. Am J Surg Pathol. 2012;36:1129-40.
44. Panos G, Karveli EA, Nikolatou O, Falagas ME. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol. 2007;82:761-5.
45. Qing X, Sun N, Chang E, French S, Ji P, Yue C. Plasmablastic lymphoma may occur as a highgrade transformation from plasmacytoma. Exp Mol Pathol. 2011;90:85-90.
46. Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: A review. Oral Dis. 2009;15:38-45.
47. Sagues M, Navarro JT, Ribera JM, Milla F. Testicular plasmablastic lymphoma as a fi rst manifestation of HIV infection. Med Clin. 2012;139:89-90.
48. Schichman SA, McClure R, Schaefer RF, Mehta P. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: A further expansion of the disease spectrum. Am J Hematol. 2004;77:291-5.
49. Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classifi cation of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. 256-7
50. Stephenson K, Peer S, Govender D, Fagan JJ. Plasmablastic lymphoma of the larynx: Report of two cases. J Laryngol Otol. 2013;127:96-9.
51. Sun J, Medeiros LJ, Lin P, Lu G, Bueso-Ramos CE, You MJ. Plasmablastic lymphoma involving the penis: A previously unreported location of a case with aberrant CD3 expression. Pathology. 2011;43:54-7.
52. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classifi cation of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
53. Tani J, Miyoshi H, Nomura T, et al. A case of plasmablastic lymphoma of the liver without human immunoDeficiency virus infection. World J Gastroenterol. 2013;19:6299-303.
54. Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: A clinically heterogenous spectrum in both HIV-positive and-negative patients. Ann Oncol. 2004;15:1673-9.
55. Tiong IS, Strauss M, Lau MB, Chiruka S. Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: A case report and literature review. Case Rep Hematol. 2013;2013:541783.
56. Tsachouridou O, Christoforidou A, Metallidis S, et al. Plasmablastic lymphoma of the oral cavity, a B cell-derived lymphoma associated with HIV infection: A case series. Eur Arch Otorhinolaryngol. 2012;269:1713-9.
57. Ustun C, Reid-Nicholson M, Nayak-Kapoor A, et al. Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol. 2009;88:351-8.
58. Valera A, Balague O, Colomo L, et al. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010;34:1686-94.
59. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profi les. Mod Pathol. 2005;18:806-15.
60. Wang HY, Fuda FS, Chen W, Karandikar NJ. Notch1 in primary effusion lymphoma: A clinicopathological study. Mod Pathol. 2010;23:773-80.
61. Wang HW, Yang W, Sun JZ, Lu JY, Li M, Sun L. Plasmablastic lymphoma of the small intestine: Case report and literature review. World J Gastroenterol. 2012;18:6677-81.
62. Zhang LY, Lin HY, Gao LX, et al. Primary central nervous system plasmablastic lymphoma presenting in human immunoDeficiency virus-negative but Epstein-Barr virus-positive patient: A case report. Diagn Pathol. 2012;7:51.